XML 29 R19.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Reporting
6 Months Ended
Jun. 30, 2025
Segment Reporting  
Segment Reporting

12.  Segment Reporting

We report segment information based on the various industries in which our businesses operate and how we manage those businesses in accordance with our investment strategies, which may include: identifying and acquiring undervalued assets and businesses, often through the purchase of distressed securities; increasing value through management, financial or other operational changes; and managing complex legal, regulatory or financial issues, which may include bankruptcy or insolvency, environmental, zoning, permitting and licensing issues. Therefore, although many of our businesses are operated under separate local management, certain of our businesses are grouped together when they operate within a similar industry, comprising similarities in products, customers, production processes and regulatory environments, and when such businesses, when considered together, may be managed in accordance with one or more investment strategies specific to those businesses.

Our reportable segments reflect the way the Company is managed, and for which separate financial information is available and evaluated regularly by the Company’s Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources and assess performance. The Chairman of the Board of Directors of our general partner, who is our CODM, reviews financial information for each segment and evaluates the results in relation to our broader business strategies. Accordingly, segment operating results are assessed based on net income from continuing operations attributable to Icahn Enterprises. Assets provided to the CODM are consistent with those reported in the condensed consolidated balance sheets, and there are no intra-entity sales or transfers, or significant expense categories regularly reviewed by the CODM beyond those disclosed in the condensed consolidated statements of operations.

Condensed Statements of Operations

Three Months Ended June 30, 2025

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

1,761

$

209

$

97

$

1

$

42

$

33

$

$

2,143

Other revenues from operations

 

 

 

154

 

 

17

 

 

1

 

 

172

Net loss from investment activities

 

(74)

 

 

 

 

 

 

 

 

(74)

Interest and dividend income

 

46

 

6

 

1

 

 

 

 

1

 

15

 

69

Gain (loss) on disposition of assets, net

 

 

1

 

(2)

 

 

48

 

 

 

 

47

Other income (loss), net

 

8

 

1

 

 

 

1

 

 

(1)

 

3

 

12

 

(20)

 

1,769

 

362

 

97

 

67

 

42

 

34

 

18

 

2,369

Expenses:

Cost of goods sold

 

 

1,839

 

144

 

85

 

1

 

33

 

16

 

 

2,118

Other expenses from operations

 

 

 

137

 

 

17

 

 

 

 

154

Dividend expense

 

7

 

 

 

 

 

 

 

 

7

Selling, general and administrative

 

3

 

42

 

113

 

13

 

6

 

10

 

14

 

6

 

207

Impairment

2

2

Restructuring, net

(2)

(2)

Interest expense

 

4

 

36

 

1

 

3

 

 

1

 

 

84

 

129

 

14

 

1,917

 

395

 

101

 

24

 

44

 

30

 

90

 

2,615

(Loss) income before income tax (expense) benefit

 

(34)

 

(148)

 

(33)

 

(4)

 

43

 

(2)

 

4

 

(72)

 

(246)

Income tax benefit

 

 

46

 

8

 

1

 

 

 

 

(10)

 

45

Net (loss) income

 

(34)

 

(102)

 

(25)

 

(3)

 

43

 

(2)

 

4

 

(82)

 

(201)

Less: net loss attributable to non-controlling interests

 

(18)

 

(18)

 

 

 

 

 

 

 

(36)

Net (loss) income attributable to Icahn Enterprises

$

(16)

$

(84)

$

(25)

$

(3)

$

43

$

(2)

$

4

$

(82)

$

(165)

Supplemental information:

Capital expenditures

$

$

41

$

22

$

9

$

21

$

3

$

$

$

96

Depreciation and amortization

$

$

94

$

17

$

5

$

7

$

2

$

7

$

$

132

Three Months Ended June 30, 2024

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

1,966

$

221

$

105

$

10

$

44

$

25

$

$

2,371

Other revenues from operations

 

 

 

162

 

 

19

 

 

1

 

 

182

Net loss from investment activities

 

(479)

 

 

 

 

 

 

 

 

(479)

Interest and dividend income

 

87

 

7

 

1

 

 

 

 

1

 

26

 

122

Gain on disposition of assets, net

 

 

 

1

 

 

 

 

 

 

1

Other income, net

 

 

4

 

 

 

 

 

 

 

4

 

(392)

 

1,977

 

385

 

105

 

29

 

44

 

27

 

26

 

2,201

Expenses:

Cost of goods sold

 

 

1,922

 

146

 

86

 

7

 

33

 

14

 

 

2,208

Other expenses from operations

 

 

 

132

 

 

18

 

 

 

 

150

Dividend expense

 

13

 

 

 

 

 

 

 

 

13

Selling, general and administrative

 

6

 

35

 

99

 

11

 

4

 

11

 

10

 

7

 

183

Restructuring, net

 

 

 

 

1

 

 

 

 

 

1

Interest expense

19

 

26

 

1

 

3

 

 

 

 

79

 

128

 

38

 

1,983

 

378

 

101

 

29

 

44

 

24

 

86

 

2,683

(Loss) income before income tax (expense) benefit

 

(430)

 

(6)

 

7

 

4

 

 

 

3

 

(60)

 

(482)

Income tax (expense) benefit

 

 

31

 

 

(2)

 

 

 

 

(33)

 

(4)

Net (loss) income

 

(430)

 

25

 

7

 

2

 

 

 

3

 

(93)

 

(486)

Less: net (loss) income attributable to non-controlling interests

 

(173)

 

17

 

 

1

 

 

 

 

 

(155)

Net (loss) income attributable to Icahn Enterprises

$

(257)

$

8

$

7

$

1

$

$

$

3

$

(93)

$

(331)

Supplemental information:

Capital expenditures

$

$

43

$

12

$

3

$

7

$

1

$

$

$

66

Depreciation and amortization

$

$

90

$

18

$

7

$

4

$

1

$

7

$

$

127

Six Months Ended June 30, 2025

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

3,407

$

407

$

191

$

1

$

83

$

56

$

$

4,145

Other revenues from operations

 

 

 

305

 

 

34

 

 

1

 

 

340

Net loss from investment activities

 

(468)

 

 

 

 

 

 

 

 

(468)

Interest and dividend income

 

101

 

16

 

2

 

 

 

 

1

 

32

 

152

(Loss) gain on disposition of assets, net

 

 

 

(4)

 

 

48

 

 

 

 

44

Other income (loss), net

 

15

 

3

 

 

2

 

1

 

(1)

 

 

3

 

23

 

(352)

 

3,426

 

710

 

193

 

84

 

82

 

58

 

35

 

4,236

Expenses:

Cost of goods sold

 

 

3,587

 

288

 

165

 

1

 

64

 

29

 

 

4,134

Other expenses from operations

 

 

 

272

 

 

33

 

 

 

 

305

Dividend expense

 

15

 

 

 

 

 

 

 

 

15

Selling, general and administrative

 

7

 

86

 

218

 

25

 

11

 

21

 

27

 

13

 

408

Impairment

12

12

Restructuring, net

5

5

Interest expense

 

10

 

71

 

2

 

6

 

 

1

 

 

167

 

257

 

32

 

3,744

 

780

 

213

 

45

 

86

 

56

 

180

 

5,136

(Loss) income before income tax benefit

 

(384)

 

(318)

 

(70)

 

(20)

 

39

 

(4)

 

2

 

(145)

 

(900)

Income tax benefit

 

 

99

 

18

 

3

 

 

 

 

(1)

 

119

Net (loss) income

 

(384)

 

(219)

 

(52)

 

(17)

 

39

 

(4)

 

2

 

(146)

 

(781)

Less: net loss attributable to non-controlling interests

 

(144)

 

(49)

 

 

(1)

 

 

 

 

 

(194)

Net (loss) income attributable to Icahn Enterprises

$

(240)

$

(170)

$

(52)

$

(16)

$

39

$

(4)

$

2

$

(146)

$

(587)

Supplemental information:

Capital expenditures

$

$

92

$

46

$

16

$

25

$

5

$

$

$

184

Depreciation and amortization

$

$

178

$

34

$

10

$

11

$

3

$

14

$

$

250

Six Months Ended June 30, 2024

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

 

Consolidated

(in millions)

 

Revenues:

    

  

  

  

  

  

  

  

  

 

  

Net sales

$

$

3,829

$

449

$

206

$

11

$

80

$

49

$

$

4,624

Other revenues from operations

 

 

 

318

 

 

36

 

 

2

 

 

356

Net loss from investment activities

 

(575)

 

 

 

 

 

 

 

 

(575)

Interest and dividend income

 

192

 

20

 

2

 

 

 

 

1

 

50

 

265

Loss on disposition of assets, net

 

(1)

 

(4)

 

 

 

 

 

 

(5)

Other income (loss), net

 

 

8

 

 

(2)

 

 

 

 

 

6

 

(383)

 

3,856

 

765

 

204

 

47

 

80

 

52

 

50

 

4,671

Expenses:

 

Cost of goods sold

 

 

3,635

 

302

 

166

 

8

 

60

 

28

 

 

4,199

Other expenses from operations

 

 

 

267

 

 

32

 

 

 

 

299

Dividend expense

 

33

 

 

 

 

 

 

 

 

33

Selling, general and administrative

 

10

 

77

 

201

 

24

 

9

 

21

 

20

 

14

 

376

Restructuring, net

 

 

 

 

1

 

 

 

 

 

1

Interest expense

 

44

 

59

 

1

 

6

 

 

 

 

154

 

264

 

87

 

3,771

 

771

 

197

 

49

 

81

 

48

 

168

 

5,172

(Loss) income before income tax (expense) benefit

 

(470)

 

85

 

(6)

 

7

 

(2)

 

(1)

 

4

 

(118)

 

(501)

Income tax (expense) benefit

 

 

18

 

4

 

(3)

 

 

 

 

(30)

 

(11)

Net (loss) income

 

(470)

 

103

 

(2)

 

4

 

(2)

 

(1)

 

4

 

(148)

 

(512)

Less: net (loss) income attributable to non-controlling interests

 

(190)

 

46

 

 

1

 

 

 

 

 

(143)

Net (loss) income attributable to Icahn Enterprises

$

(280)

$

57

$

(2)

$

3

$

(2)

$

(1)

$

4

$

(148)

$

(369)

Supplemental information:

 

Capital expenditures

$

$

90

$

28

$

5

$

9

$

2

$

$

$

134

Depreciation and amortization

$

$

182

$

37

$

13

$

7

$

3

$

14

$

$

256

Disaggregation of Revenue

In addition to the condensed statements of operations by reporting segment above, we provide additional disaggregated revenue information for our Energy and Automotive segments below.

Energy

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2025

    

2024

    

2025

    

2024

(in millions)

Petroleum products

$

1,558

$

1,792

3,033

$

3,510

Renewable products

36

41

64

58

Nitrogen fertilizer products

 

167

 

133

 

310

 

261

$

1,761

$

1,966

$

3,407

$

3,829

Automotive

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2025

    

2024

    

2025

    

2024

(in millions)

Automotive Services

$

355

$

363

$

688

$

719

Aftermarket Parts

5

2

18

Total revenue from customers

$

355

$

368

690

737

Lease revenue outside the scope of ASC 606

8

15

22

30

Total Automotive net sales and other revenues from operations

$

363

$

383

$

712

$

767

Condensed Balance Sheets

June 30, 2025

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

13

$

596

$

32

$

9

$

32

$

3

$

33

$

1,086

$

1,804

Cash held at consolidated affiliated partnerships and restricted cash

 

2,485

 

 

8

 

 

 

3

 

 

176

 

2,672

Investments

 

1,939

 

19

 

 

 

14

 

 

 

 

1,972

Accounts receivable, net

 

 

245

 

26

 

73

 

12

 

26

 

38

 

 

420

Inventories, net

 

 

503

 

174

 

108

 

 

98

 

22

 

 

905

Property, plant and equipment, net

 

 

2,461

 

806

 

126

 

334

 

55

 

 

4

 

3,786

Goodwill and intangible assets, net

 

 

149

 

324

 

21

 

 

21

 

156

 

 

671

Other assets

 

1,277

 

466

 

459

 

93

 

91

 

18

 

4

 

201

 

2,609

Total assets

$

5,714

$

4,439

$

1,829

$

430

$

483

$

224

$

253

$

1,467

$

14,839

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

1,116

$

1,501

$

772

$

103

$

43

$

43

$

56

$

73

$

3,707

Securities sold, not yet purchased, at fair value

 

996

 

 

 

 

 

 

 

 

996

Debt

 

 

1,861

 

25

 

147

 

1

 

15

 

 

4,664

 

6,713

Total liabilities

 

2,112

 

3,362

 

797

 

250

 

44

 

58

 

56

 

4,737

 

11,416

Equity attributable to Icahn Enterprises

 

2,464

 

550

 

1,032

 

165

 

439

 

166

 

197

 

(3,270)

 

1,743

Equity attributable to non-controlling interests

 

1,138

 

527

 

 

15

 

 

 

 

 

1,680

Total equity

 

3,602

 

1,077

 

1,032

 

180

 

439

 

166

 

197

 

(3,270)

 

3,423

Total liabilities and equity

$

5,714

$

4,439

$

1,829

$

430

$

483

$

224

$

253

$

1,467

$

14,839

December 31, 2024

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

9

$

987

$

133

$

6

$

25

$

4

$

42

$

1,397

$

2,603

Cash held at consolidated affiliated partnerships and restricted cash

 

2,449

 

 

8

 

 

2

 

4

 

 

173

 

2,636

Investments

 

2,272

 

24

 

 

 

14

 

 

 

 

2,310

Accounts receivable, net

 

 

295

 

30

 

75

 

14

 

28

 

37

 

 

479

Inventories, net

 

 

502

 

168

 

109

 

 

93

 

25

 

 

897

Property, plant and equipment, net

 

 

2,504

 

808

 

124

 

350

 

53

 

 

4

 

3,843

Goodwill and intangible assets, net

 

 

159

 

328

 

21

 

 

19

 

170

 

 

697

Other assets

 

1,660

 

280

 

464

 

90

 

90

 

19

 

7

 

204

 

2,814

Total assets

$

6,390

$

4,751

$

1,939

$

425

$

495

$

220

$

281

$

1,778

$

16,279

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

817

$

1,509

$

809

$

107

$

42

$

43

$

72

$

77

$

3,476

Securities sold, not yet purchased, at fair value

 

1,373

 

 

 

 

 

 

 

 

1,373

Debt

 

 

1,919

 

31

 

144

 

1

 

15

 

 

4,699

 

6,809

Total liabilities

 

2,190

 

3,428

 

840

 

251

 

43

 

58

 

72

 

4,776

 

11,658

Equity attributable to Icahn Enterprises

 

2,703

 

685

 

1,099

 

159

 

447

 

162

 

209

 

(2,998)

 

2,466

Equity attributable to non-controlling interests

 

1,497

 

638

 

 

15

 

5

 

 

 

 

2,155

Total equity

 

4,200

 

1,323

 

1,099

 

174

 

452

 

162

 

209

 

(2,998)

 

4,621

Total liabilities and equity

$

6,390

$

4,751

$

1,939

$

425

$

495

$

220

$

281

$

1,778

$

16,279